{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:23:53Z","timestamp":1791951833385,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277108"],"award-info":[{"award-number":["22277108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877099"],"award-info":[{"award-number":["21877099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118639","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:37:31Z","timestamp":1770136651000},"page":"118639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design and optimization of N-(3-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amide derivatives as potent anti-inflammatory agents against LPS-induced acute lung injury"],"prefix":"10.1016","volume":"307","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-7600","authenticated-orcid":false,"given":"Xingxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118639_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118639_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/ALN.0000000000003571","article-title":"Eltzschig. Acute respiratory distress syndrome contemporaty management and novel approaches during COVID-19","volume":"134","author":"Williams","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2026.118639_bib3","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.bmcl.2015.05.030","article-title":"Design, synthesis and biological evaluation of paralleled aza resveratrol-chalcone compounds as potential anti-inflammatory agents for the treatment of acute lung injury","volume":"25","author":"Chen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118639_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/138955712800626728","article-title":"Meridianins: marine-derived potent kinase inhibitors","volume":"12","author":"Bharate","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib5","first-page":"1042","article-title":"Meridianin G and its analogs as antimalarial agents","volume":"4","author":"Bharate","year":"2013","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib6","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1021\/jm200464w","article-title":"Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives","volume":"54","author":"Giraud","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2015.05.020","article-title":"Synthesis, antimalarial and antitubercular activities of meridianin derivatives","volume":"98","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib8","first-page":"463","article-title":"Synthesis, characterization and evaluation of analgesic and anti-inflammatory activities of some novel indoles","volume":"10","author":"Chavan","year":"2011","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2026.118639_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/molecules25030698","article-title":"A review of small molecule inhibitors and functional probes of human cathepsin L","volume":"25","author":"Dana","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118639_bib10","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1126\/sciadv.adf4313","article-title":"Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis","volume":"9","author":"Zhu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118639_bib11","article-title":"Cathepsin L plays a role in quinolinic acid-induced NF-kb activation and excitotoxicity in rat striatal neurons","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118639_bib12","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/pr7007779","article-title":"Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies","volume":"7","author":"Liu","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejmech.2026.118639_bib13","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1021\/acs.jmedchem.3c00359","article-title":"Design, synthesis, and bioevaluation of novel MyD88 inhibitor c17 against acute lung injury derived from the virtual screen","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2018.09.068","article-title":"Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury","volume":"161","author":"Chen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib15","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1021\/acs.jmedchem.3c00832","article-title":"Discovery of the diphenyl 6-oxo-1, 6-dihydropyridazine-3-carboxylate\/carboxamide analogue J27 for the treatment of acute lung injury and sepsis by targeting JNK2 and inhibiting the JNK2-NF-kB\/MAPK pathway","volume":"66","author":"Liao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118639_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.fsi.2022.03.008","article-title":"TAK1 confers antibacterial protection through mediating the activation of MAPK and NF-kB pathways in shrimp","volume":"123","author":"Wang","year":"2022","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.ejmech.2026.118639_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111024","article-title":"Inhibition of cathepsin L ameliorates inflammation through the A20\/NF-kappaB pathway in endotoxin-induced acute lung injury","volume":"27","author":"Yang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.118639_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.resp.2014.10.006","article-title":"Biomarkers in acute lung injury","volume":"209","author":"Mokra","year":"2015","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.118639_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08820139.2012.750667","article-title":"Biomarkers of lung injury in critical care medicine: past, present, and future","volume":"42","author":"Tunceroglu","year":"2013","journal-title":"Immunol. Investig."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:38:29Z","timestamp":1775482709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":19,"alternative-id":["S022352342600084X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118639","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and optimization of N-(3-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amide derivatives as potent anti-inflammatory agents against LPS-induced acute lung injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118639"}}